CA1000279A - Quinoline derivatives having pharmacological effects - Google Patents

Quinoline derivatives having pharmacological effects

Info

Publication number
CA1000279A
CA1000279A CA162,916A CA162916A CA1000279A CA 1000279 A CA1000279 A CA 1000279A CA 162916 A CA162916 A CA 162916A CA 1000279 A CA1000279 A CA 1000279A
Authority
CA
Canada
Prior art keywords
pharmacological effects
quinoline derivatives
quinoline
derivatives
pharmacological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA162,916A
Other languages
English (en)
Other versions
CA162916S (en
Inventor
Theodorus A.C. Boschman
Jacob G. Korsloot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL7201675A external-priority patent/NL7201675A/xx
Priority claimed from NL7215366A external-priority patent/NL7215366A/xx
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Application granted granted Critical
Publication of CA1000279A publication Critical patent/CA1000279A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA162,916A 1972-02-09 1973-02-05 Quinoline derivatives having pharmacological effects Expired CA1000279A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7201675A NL7201675A (xx) 1972-02-09 1972-02-09
NL7215366A NL7215366A (en) 1972-11-14 1972-11-14 P-dioxino(2,3-g)quinolines - diuretics, saluretics and hypotensives

Publications (1)

Publication Number Publication Date
CA1000279A true CA1000279A (en) 1976-11-23

Family

ID=26644729

Family Applications (1)

Application Number Title Priority Date Filing Date
CA162,916A Expired CA1000279A (en) 1972-02-09 1973-02-05 Quinoline derivatives having pharmacological effects

Country Status (16)

Country Link
US (1) US3865832A (xx)
JP (1) JPS5727112B2 (xx)
AR (1) AR211510A1 (xx)
AT (1) AT323740B (xx)
BE (1) BE795265A (xx)
CA (1) CA1000279A (xx)
CH (1) CH593285A5 (xx)
DE (1) DE2303496A1 (xx)
DK (1) DK138120B (xx)
ES (1) ES411374A1 (xx)
FI (1) FI55847C (xx)
FR (1) FR2181708B1 (xx)
GB (1) GB1366834A (xx)
IL (1) IL41471A (xx)
PH (1) PH14448A (xx)
SE (1) SE416467B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036962A (en) * 1974-08-12 1977-07-19 E. I. Du Pont De Nemours And Co. 6,7-Methylenedioxy-1-(2,2,2-trifluoroethyl)-4(1H)-quinolone-3-carboxylic acid and its salts and esters
US4179506A (en) * 1978-11-13 1979-12-18 Warner-Lambert Company New pyridobenzodioxin compounds and methods for their production
FR2846327B1 (fr) * 2002-10-25 2006-03-24 Merck Sante Sas Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
JP5755217B2 (ja) * 2009-03-30 2015-07-29 トランステック・ファーマ，エルエルシー 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法
CN113717185B (zh) * 2021-08-19 2023-04-11 云南省烟草农业科学研究院 雪茄烟根茎中一种具有抗菌活性的喹啉生物碱化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1076828A (en) * 1963-12-12 1967-07-26 Warner Lambert Pharmaceutical Methylenedioxy quinoline derivatives
DE1908548A1 (de) * 1968-02-29 1970-11-05 Warner Lambert Co Chinolinderivate
CA942310A (en) * 1969-07-09 1974-02-19 Mitsuo Nakashita Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
DE2030899A1 (de) * 1970-06-18 1971-12-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen Chinolincarbonsäurederivate

Also Published As

Publication number Publication date
IL41471A0 (en) 1973-04-30
FI55847B (fi) 1979-06-29
GB1366834A (en) 1974-09-11
FR2181708A1 (xx) 1973-12-07
BE795265A (fr) 1973-08-09
DE2303496A1 (de) 1973-08-23
SE416467B (sv) 1981-01-05
JPS4886896A (xx) 1973-11-15
DK138120B (da) 1978-07-17
ES411374A1 (es) 1976-07-01
FR2181708B1 (xx) 1975-10-10
US3865832A (en) 1975-02-11
JPS5727112B2 (xx) 1982-06-08
DK138120C (xx) 1978-12-04
FI55847C (fi) 1979-10-10
AT323740B (de) 1975-07-25
CH593285A5 (xx) 1977-11-30
AR211510A1 (es) 1978-01-30
IL41471A (en) 1975-12-31
PH14448A (en) 1981-07-23

Similar Documents

Publication Publication Date Title
AU467944B2 (en) 4-aminoquinoline derivatives
AU467361B2 (en) Q-aryl-4-substituted piperidinoalkanol derivatives
CA1019738A (en) Isothiocyanopyridine derivatives
AU470719B2 (en) Oxazinoindole-and thiazinoinindole derivatives
CA1000279A (en) Quinoline derivatives having pharmacological effects
AU475007B2 (en) Morphinan derivatives
CA1020946A (en) 1-phenoxy-3-phenoxyethylamino-2-propanol derivatives
AU467405B2 (en) Diphenylalkyllactamimide derivatives
CA1018161A (en) Indan-1-carboxamide derivatives
CA1006514A (en) Beta-aminoketone derivatives
AU470763B2 (en) Pyrano-and thiopyranoindole derivatives
CA978526A (en) Pyrano- and thiopyranoindole derivatives
CA1012147A (en) Indolo quinoline derivatives
AU475423B2 (en) Novel dioxino quinoline derivatives having pharmacological effects
CA895297A (en) Isoquinoline derivatives
CA895837A (en) Thiazino isoquinoline derivatives
AU480934B2 (en) Isoquinolinium derivatives
CA898253A (en) Styryl-naphthalene derivatives
CA910311A (en) En-amine derivatives
CA899353A (en) 1-hydroxyproline derivatives
AU477427B2 (en) 2-fluoro-substituted thiazanthene derivatives
AU483221B2 (en) Benzo-di-pyran derivatives
AU482792B2 (en) Indan-1-carboxamide derivatives
CA891502A (en) Benhydrylquinuclidinol derivatives
CA892056A (en) Sulphonamidopyrazolinone derivatives